IDH1 and glioma: We performed either DMSO (vehicle) or RSL3 treatments for 18 h on organotypic slice cultures from six gliomas, including five primary GBMs and an IDH1-mutant anaplastic astrocytoma (Fig. 7A–F, Table EV2).